74 related articles for article (PubMed ID: 37232900)
1. New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia.
Roškar Z; Dreisinger M; Tič P; Homšak E; Bevc S; Goropevšek A
Biosensors (Basel); 2023 May; 13(5):. PubMed ID: 37232900
[TBL] [Abstract][Full Text] [Related]
2. STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.
Goropevšek A; Gorenjak M; Gradišnik S; Dai K; Holc I; Hojs R; Krajnc I; Pahor A; Avčin T
J Leukoc Biol; 2017 Jun; 101(6):1405-1418. PubMed ID: 28254841
[TBL] [Abstract][Full Text] [Related]
3. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
4. Assessing IL-2-Induced STAT5 Phosphorylation in Fixed, Permeabilized Foxp3
Li C; Park JH
STAR Protoc; 2020 Dec; 1(3):100195. PubMed ID: 33377089
[TBL] [Abstract][Full Text] [Related]
5. [The percentage of regulatory T cells in peripheral blood of chronic lymphocytic leukemia patients and the correlations with clinical prognosis].
Xie P; Pang N; Guo X; Wang L; Zhao F; Wang X; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1307-11. PubMed ID: 24321076
[TBL] [Abstract][Full Text] [Related]
6. Decreased regulatory function of CD4
Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
[TBL] [Abstract][Full Text] [Related]
7. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
8. Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assay.
Wakui M; Uwamino Y; Yatabe Y; Nakagawa T; Sakai A; Kurafuji T; Shibata A; Tomita Y; Noguchi M; Tanabe A; Arai T; Ohno A; Yokota H; Uno S; Yamasawa W; Sato Y; Ikeda M; Yoshimura A; Hasegawa N; Saya H; Murata M
Eur J Immunol; 2022 Dec; 52(12):1961-1971. PubMed ID: 36250411
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies.
Maharaj K; Uriepero A; Sahakian E; Pinilla-Ibarz J
Front Immunol; 2022; 13():943354. PubMed ID: 35979372
[TBL] [Abstract][Full Text] [Related]
10. Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.
Whyte CE; Singh K; Burton OT; Aloulou M; Kouser L; Veiga RV; Dashwood A; Okkenhaug H; Benadda S; Moudra A; Bricard O; Lienart S; Bielefeld P; Roca CP; Naranjo-Galindo FJ; Lombard-Vadnais F; Junius S; Bending D; Ono MM; Hochepied T; Halim TYF; Schlenner S; Lesage S; Dooley J; Liston A
J Exp Med; 2022 Jul; 219(7):. PubMed ID: 35699942
[TBL] [Abstract][Full Text] [Related]
11. Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components.
Busà R; Sorrentino MC; Russelli G; Amico G; Miceli V; Miele M; Di Bella M; Timoneri F; Gallo A; Zito G; Di Carlo D; Conaldi PG; Bulati M
Front Immunol; 2022; 13():856657. PubMed ID: 35401503
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab.
Bacova B; Kohutova Z; Zubata I; Gaherova L; Kucera P; Heizer T; Mikesova M; Karel T; Novak J
Clin Exp Med; 2023 Jun; 23(2):371-379. PubMed ID: 35352210
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.
Hallek M; Al-Sawaf O
Am J Hematol; 2021 Dec; 96(12):1679-1705. PubMed ID: 34625994
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
